ES2062329T3 - Composiciones anestesicas por via oral. - Google Patents

Composiciones anestesicas por via oral.

Info

Publication number
ES2062329T3
ES2062329T3 ES90301309T ES90301309T ES2062329T3 ES 2062329 T3 ES2062329 T3 ES 2062329T3 ES 90301309 T ES90301309 T ES 90301309T ES 90301309 T ES90301309 T ES 90301309T ES 2062329 T3 ES2062329 T3 ES 2062329T3
Authority
ES
Spain
Prior art keywords
around
anesthetic
oral
saccharine
animals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90301309T
Other languages
English (en)
Inventor
William Joseph Kelleher
William John Mcclintock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richardson Vicks Inc
Original Assignee
Richardson Vicks Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Vicks Inc filed Critical Richardson Vicks Inc
Application granted granted Critical
Publication of ES2062329T3 publication Critical patent/ES2062329T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE DESCUBREN COMPOSICIONES FARMACEUTICAS ANESTESICAS ORALES COMPRENDIENDO: (A) DE ALREDEDOR DE 0,02% A ALREDEDOR DE 25% DE UNA SAL ACIDA FARMACEUTICAMENTE ACEPTABLE DE UNA (BETA)-AMINOPROPIOFENONA, TAL COMO DICLONINA HCL; (B) DE ALREDEDOR DE 0,02% A ALREDEDOR DE 20% DE SACARINA: Y (C) DE ALREDEDOR DE 1% A ALREDEDOR DEL 99% DE UN PORTADOR ORAL FARMACEUTICAMENTE ACEPTABLE. TAMBIEN SE PROVEEN METODOS PARA PROVEER UN EFECTO ANESTESICO EN HUMANOS O ANIMALES, LOS CUALES COMPRENDEN ADMINISTRACION ORAL A DICHO HUMANO O ANIMAL UNA SEGURA Y EFECTIVA CANTIDAD DE ESTAS COMPOSICIONES FARMACEUTICAS. TAMBIEN SE PROVEEN NUEVOS PROCESOS PARA LA FABRICACION DE PASTILLAS ANESTESICAS CONTENIENDO UNA (BETA)-AMINOPROPIOFENONA LINEAL CON SACARINA.
ES90301309T 1989-02-15 1990-02-07 Composiciones anestesicas por via oral. Expired - Lifetime ES2062329T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/311,155 US4931473A (en) 1989-02-15 1989-02-15 Anesthetic oral compositions

Publications (1)

Publication Number Publication Date
ES2062329T3 true ES2062329T3 (es) 1994-12-16

Family

ID=23205653

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90301309T Expired - Lifetime ES2062329T3 (es) 1989-02-15 1990-02-07 Composiciones anestesicas por via oral.

Country Status (10)

Country Link
US (1) US4931473A (es)
EP (1) EP0383481B1 (es)
JP (1) JPH03197427A (es)
AU (1) AU639436B2 (es)
CA (1) CA2010022C (es)
DE (1) DE69006041T2 (es)
ES (1) ES2062329T3 (es)
FI (1) FI900724A0 (es)
IE (1) IE63154B1 (es)
NZ (1) NZ232537A (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580577A (en) * 1990-01-11 1996-12-03 Herzenberg; Leonard A. Method of treating the symptoms of human rhinovirus infection
US5100898A (en) * 1990-01-25 1992-03-31 Richardson-Vicks Inc. Antitussive liquid compositions containing dyclonine
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
AU4816200A (en) * 1999-05-03 2000-11-17 Advanced Research And Technology Institute, Inc. Methods and compositions for controlling dental caries, and recombinant smaa polypeptides useful for same
US20160060235A1 (en) * 2013-03-29 2016-03-03 National University Corporation Kumamoto University Therapeutic Agent for Type 2 Diabetes
IT201600098338A1 (it) * 2016-09-30 2018-03-30 Univ Degli Studi Padova Composti 1-fenilpropanone e loro impiego

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2298767A (en) * 1940-06-03 1942-10-13 Union Special Machine Co Closure hinge means
US2868689A (en) * 1956-10-09 1959-01-13 Allied Lab Inc Pharmaceutical preparations containing dyclonine hydrochloride and chlorobutanol
BE569430A (es) * 1957-07-17
US3231531A (en) * 1960-07-13 1966-01-25 Ferro Corp Polyvinyl chloride resins stabilized with a combination of a calcium salt, zinc salt, a phosphorus compound, and a sulphate or saccharin
US3138528A (en) * 1962-05-01 1964-06-23 Olin Mathieson Stable, aqueous solutions of 21-phosphate esters of 21-hydroxy steroids
US3511914A (en) * 1967-01-31 1970-05-12 Schering Corp Throat lozenge vehicle
US3832460A (en) * 1971-03-19 1974-08-27 C Kosti Anesthetic-vasoconstrictor-antihistamine composition for the treatment of hypertrophied oral tissue
US4139627A (en) * 1977-10-06 1979-02-13 Beecham Inc. Anesthetic lozenges
US4140772A (en) * 1978-02-21 1979-02-20 Dart Industries Inc. Stabilized hydrogen peroxide solutions
US4499108A (en) * 1983-06-08 1985-02-12 Schering Corporation Stable pleasant-tasting albuterol sulfate pharmaceutical formulations
US4808410A (en) * 1987-12-16 1989-02-28 Richardson-Vicks Inc. Pharmaceutical compositions containing dyclonine HC1 and phenol

Also Published As

Publication number Publication date
IE63154B1 (en) 1995-03-22
EP0383481A3 (en) 1991-04-10
CA2010022C (en) 1996-03-05
DE69006041D1 (de) 1994-03-03
IE900537L (en) 1990-08-15
AU4939690A (en) 1990-08-23
CA2010022A1 (en) 1990-08-15
NZ232537A (en) 1992-11-25
EP0383481B1 (en) 1994-01-19
US4931473A (en) 1990-06-05
EP0383481A2 (en) 1990-08-22
FI900724A0 (fi) 1990-02-14
DE69006041T2 (de) 1994-08-11
AU639436B2 (en) 1993-07-29
JPH03197427A (ja) 1991-08-28

Similar Documents

Publication Publication Date Title
ES485061A1 (es) Un procedimiento para preparar el siomero sin descompuestos de acido 3-cefem-4-carboxilico sustituido en las posiciones 3 y 7
ES2063011T3 (es) Agentes antibacteriales de quinolonas y naftiridinas que contienen un alfa-aminoacido en la cadena lateral del 7-sustituyente.
ES2002089T3 (es) Nuevas formulaciones farmaceuticas con liberacion programada que contienen antiflogisticos.
ES2062392T3 (es) Medicamentos que comprenden salmeterol y fluticasona.
DE69127470D1 (de) Verstärkung der unterdrückungsregulation von autoimmunkrankheiten durch orale oder enterale verabreichung von autoantigenen
ES2162615T3 (es) Metodo para tratar o prevenir diabetes de tipo 1 mediante la administracion oral de insulina.
IT8221278A0 (it) Composizione farmaceutica contenente 24,25-diidrossicolecalciferolo come ingrediente attivo
ES8306483A1 (es) Procedimiento de preparacion de las dibezooxepinas sustituidas y de sus sales de adicion con un acido mineral u organico
HUT57204A (en) Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them
ES2062329T3 (es) Composiciones anestesicas por via oral.
IT8025159A0 (it) Preparato medicinale ad azione citostatica, nonche' derivati dell'acido isocianurico eprocedimento per la loro preparazione.
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
GB2021409A (en) Pharmaceutical composition
ATE27157T1 (de) Cycloalkylderivate von benzisoselenazolonen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
IT7825386A0 (it) N-aril-n'-alchil-s-alchil-isotioure e, procedimenti per la loro preparazione e loro impiego come prodotti per combattere organismi nocivi animali e vegetali.
IT8219650A0 (it) Derivati dagli acidi alfa o beta mercaptopropionilammidoacetici, processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo.
DE3275060D1 (en) Use of beta-(1-adamantyl)-alpha, alpha-dimethylethylamine for the manufacture of a medicament for the treatment of otitis externa in dogs
SE7708622L (sv) 2-bensyl-perhydroazepiner, sett for framstellning derav och lekemedel, innehallande dem
IT8349055A0 (it) B-osso-l-carbammoil-pirrolpropionitrile, procedimento per la loro produzione, preparati farmaceutici con tenenti questi composti, nonche' il loro impiego terapeutico
ZA824649B (en) New optically active dipeptides, process for their preparation and pharmaceutical products containing these compounds
IT8422646A0 (it) Contengono. composti derivati dell'acido beta-ossimino-propionico adattivita' terapeutica, procedimento per la loro preparazione e composizioni farmaceutiche che li
IT8648565A0 (it) Derivati di acido tiofenacetico,procedimento per la loro preparazione, composizioni farmaceutiche che licontengono e loro impiego come medicamenti
FR2394515A1 (fr) Nouveaux derives de prostane, leur procede de preparation et medicament les contenant
FR2567755B1 (fr) Nouveau medicament anti-tumoral contenant comme ingredient actif le triacetoxy-1,8,9 anthracene
IT8348726A0 (it) Composti di amminoimidazolile, procedimenti per la loro produzione e preparati farmaceutici che contengono questi composti

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 383481

Country of ref document: ES